Millipore Introduces Bench Top TFF System For Process Development At INTERPHEX 2008

Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, recently announced that the new Cogent µScale Tangential Flow Filtration (TFF) system for both process development and low volume sample preparation.

The Cogent µScale TFF System is an easy-to-use, semi-automated bench top solution that has been designed to fully support TFF process development at the "microscale" using up to three Pellicon 3 88 cm² cassettes (264 cm²). With a low minimum working volume, the ability to operate at feed pressures up to 80psig (5.5 bar) and very low pulsation, the system fully supports both scaling studies and low volume Ultrafiltration & Diafiltration (UF/DF) work using Pellicon 3 cassettes. The system can also be configured to process up to three Pellicon XL-50 TFF devices, and is ideal for purifying and concentrating monoclonal antibodies, recombinant proteins, vaccines, gene therapy constructs, blood serum products and other cell derived components.

Key Benefits include:

• Versatile system performance – an excellent tool for microscale process development, membrane screening and everyday low-volume UF/DF work, including fed-batch processing
• Ease–of-use – an intuitive, multilingual touch screen interface makes it simple to set-up and execute runs without the need for complicated programming
• User-configurable alarm set points and automated data acquisition enable greater productivity
• Feed pressures up to 80 psig (5.5 bar) enable higher DeltaP and TMP processing

In combination with Millipore's industry leading Pellicon 3 TFF cassette technology, the Cogent µScale TFF System will enhance the productivity of process developers and research scientists alike. To learn more, please visit www.millpore.com

Millipore has evolved from a high performance filtration products and services company into a leading provider of tools and services and a key partner of choice for Life Science customers. We've transformed ourselves through R&D investment, organic growth, and acquisitions such as Chemicon, Upstate, Linco, Celliance, Newport Bio, NovAseptic AB and MicroSafe. The integrated Millipore offers more innovative technologies and stronger application support to streamline processes and provide consistently reliable results.

About Millipore
Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees in 47 countries worldwide. For more information, visit www.millpore.com.

SOURCE: Millipore Corporation